Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Stamataki, Petroula ^a   Papazafiropoulou, Athanasia ^b   Elefsiniotis, Ioannis ^c   Giannakopoulou, Margarita ^c   Brokalaki, Hero ^c   Apostolopoulou, Eleni ^c   Sarafis, Pavlos ^a   Saroglou, George ^c  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b 3rdDepartment of Internal Medicine and Center of Diabetes   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; GREECE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 35; LOWEST INCOME GROUP; NONHUMAN; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SAMPLE SIZE; SEXUAL BEHAVIOR; SEXUALITY; VIRUS DETECTION; VIRUS INFECTION; CLASSIFICATION; DRINKING BEHAVIOR; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; SOCIOECONOMICS; VAGINA SMEAR;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; AMBULATORY CARE FACILITIES; FEMALE; GENOTYPE; GREECE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77649086441     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-27     Document Type: Article

References (45)

1. Pisani P, Bari F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002, 97:72-81. 10.1002/ijc.1571, 11774246.
2. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human Papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995, 87:796-802. 10.1093/jnci/87.11.796, 7791229.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-9. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
4. Burd EM. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews 2003, 16:1-17. 10.1128/CMR.16.1.1-17.2003, 145302, 12525422.
5. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003, 9:348-59. 10.1097/00130404-200309000-00004, 14690309.
6. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999, 354:20-25. 10.1016/S0140-6736(98)12490-X, 10406360.
7. Rozendaal L, Walboomers JMM, Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst Th JM, Van Ballegooijen M, Meijer CJLM. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996, 68:766-769. 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z, 8980181.
8. Meijer CJLM, Helmerhorst T, Rozendaal L, Linden JC, Voorhorst FJ, Walboomers JMM. HPV typing and testing in gynaecological pathology: has the time come?. Histopatology 1998, 33:83-86.
9. Harro CD, Pang YY, Roden RB, Hildesheim A, Wang Z, Reynolds MJ, Mast TC, Robinson R, Murphy BR, Karron RA, Dillner J, Schiller JT, Lowy DR. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst 2001, 93:284-292. 10.1093/jnci/93.4.284, 11181775.
10. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88:63-73. 10.1038/sj.bjc.6600688, 2376782, 12556961.
11. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 1989, 7:209-214.
12. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, . International Agency for Research on Cancer Multicenter Cervical Cancer Study Group Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527. 10.1056/NEJMoa021641, 12571259, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.
13. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. Am J Epidemiol 2008, 168:123-137. 10.1093/aje/kwn036, 18483125.
14. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819. 10.1001/jama.297.8.813, 17327523.
15. Evander M, Edlund K, Bodén E, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. Journal of Clinical Microbiology 1992, 30:987-992. 265198, 1315341.
16. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. Baseline cytology, human papillomavirustesting, and risk for cervical neoplasia: a 10-year cohort analysis. Journal of the National Cancer Institute 2003, 95:46-52.
17. Kroupis C, Thomopoulou G, Papathomas TG, Vourlidis N, Lazaris AC. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol Infect 2007, 135:943-950. 10.1017/S095026880700876X, 17553178.
18. Labropoulou V, Diakomanolis E, Dailianas S, Kalpaktsoglou K, Balamotis A, Mavromara P. Type-specific prevalence of genital human papillomaviruses in benign, premalignant, and malignant biopsies in patients from Greece. Sexually Transmitted Diseases 1997, 24:469-474. 10.1097/00007435-199709000-00005, 9293610.
19. Agorastos T, Bontis J, Lambropoulos AF, Constantinidis TC, Nasioutzini M, Tagou C, Katsouyiannopoulos V. Epidemiology of human papillomavirus infection in Greek asymptomatic women. Eur J Cancer Prev 1995, 4:159-167. 10.1097/00008469-199504000-00006, 7767242.
20. Agorastos T, Dinas K, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, de Sanjose S. Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece. European Journal of Cancer Prevention 2004, 13:145-147. 10.1097/00008469-200404000-00010, 15100583.
21. de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, Català I, Meijer CJ, Snijders PJ, Herrero R, Bosch FX. Cervical Human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003, 30:788-793. 10.1097/01.OLQ.0000080177.82204.E0, 14520179.
22. Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen Thuy TT, Nguyen HN, Nguyen BD, Ashley R, Snijders PJ, Meijer CJ, Muñoz N, Parkin DM, Franceschi S. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003, 104:213-220. 10.1002/ijc.10936, 12569577.
23. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Touzé A, Muñoz N, Snijders PJ, Meijer CJ, Coursaget P, Franceschi S. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003, 103:413-421. 10.1002/ijc.10825, 12471626.
24. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, Hernández P, Salmerón J, Hernández M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001, 91:412-420. 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M, 11169968.
25. Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, Brule AJ, Meijer CJ, Muñoz N, Herrero R, . Proyecto Concordia Collaborative Group Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003, 30:593-599. 10.1097/01.OLQ.0000085181.25063.6C, 12897679, Proyecto Concordia Collaborative Group.
26. Clifford GM, Rana RK, Franceschi S, Smith J, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:1157-1164. 10.1158/1055-9965.EPI-04-0812, 15894666.
27. Dokianakis DN, Papaefthimiou M, Tsiveleka A, Spandidos D. High prevalence of HPV 18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from cervical cytological smears. Oncol Rep 1999, 66:1327-1331.
28. Vassilandonopoulou G, Panotopoulou E, Fotiou S, Tserkezoglou A, Machera E, Kottaridis S. Humanpapillomaviruses in cervical cancer I. HPV-16 and 18 predominate in the Greek population. Anticancer Res 1997, 17:117-120.
29. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994, 69:114-119. 1968795, 8286192.
30. Chaouki N, Bosch FX, Muñoz N, Meijer CJLM, Gueddari B, El G, Deacon J, Castellsague X, Walboomers JMM. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998, 75:546-554. 10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T, 9466654.
31. Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJLM, Walboomers JMM. Risk factors for cervical cancer in Thailand: a case - control study. J Natl Cancer Inst 1998, 90:50-57. 10.1093/jnci/90.1.50, 9428783.
32. Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJLM, Walboomers JMM. Causes of cervical cancer in the Philippines: a case - control study. J Natl Cancer Inst 1998, 90:43-49. 10.1093/jnci/90.1.43, 9428782.
33. Rolon PA, Smith JS, Muñoz N, Klug SJ, Herrero R, Bosch X, Llamosas F, Meijer CJLM, Walboomers JMM. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000, 85:486-491. 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S, 10699919.
34. Jacobs MV, Walboomers JMM, Snijders PJF, Voorhorst FJ, Daalmeijer NF, Meijer CJLM. Age-related distribution patterns of 37 mucosotropic HPV types in women with cytologically normal cervical smears: decreased high risk/low risk ratio at older age. Int J Cancer 2000, 87:221-227. 10.1002/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2, 10861478.
35. Herrero R, Hildesheim A, Bratti C, Sherman M, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Schiffman MH. A population-based study of all grades of cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000, 92:464-473. 10.1093/jnci/92.6.464, 10716964.
36. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993, 20:274-278.
37. Kjaer SK, Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ. Determinants of genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal PAP smear: are there different risk profiles for oncogenic and non oncogenic HPV types?. Cancer Epidemiol Biomarkers Prev 1997, 6:799-805.
38. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996, 23:333-341.
39. Sikström B, Hellberg D, Nilsson S, Mårdh PA. Smoking, alcohol, sexual behaviour and drug use in women with cervical human papillomavirus infection. Arch Gynecol Obstet 1995, 256:131-137. 10.1007/BF01314641, 7574905.
40. Tolstrup J, Munk C, Thomsen BL, Svare E, Brule AJ, Grønbaek M, Meijer C, Kjaer Krüger S. The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women. Acta Obstet Gynecol Scand 2006, 85:1114-1119. 10.1080/00016340600677027, 16929418.
41. Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Zakharova T, Pajanidi J, Podistov J, Chemeris G, Sozaeva L, Lipova E, Tsidaeva I, Ivanchenko O, Pshepurko A, Zakharenko S, Nerovjna R, Kljukina L, Erokhina O, Branovskaja M, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen K. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the new independent states of the Former Soviet Union. Journal of Clinical Microbiology 2004, 42:505-511. 10.1128/JCM.42.2.505-511.2004, 344495, 14766808.
42. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007, 110:87-95.
43. Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, Studentsov YY, McAdams M, Schiffman M. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004, 13:1574-1582.
44. Peevor R, Bowden S, Jones J, Fiander AN, Hibbitts S. Human Papillomavirus negative but dyskaryotic cervical cytology: re-analysis of molecular testing. J Clin Virol 2009, 44:322-324. 10.1016/j.jcv.2009.01.015, 19264544.
45. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002, 288:1749-1757. 10.1001/jama.288.14.1749, 12365959.